Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Celltech Wins Fast-Track Status For Crohn's Disease Drug

Sep. 16, 1998

Consortium Gets Funding For Drug-Delivery Work

Sep. 16, 1998

IsoTis Effort Nets US$5M For Tissue Replacements

Sep. 9, 1998

TAB Trims Directors, Plans £20M Financing After Move

Sep. 9, 1998

Infogen, Lion Enter Hunt For Heart Disease Genes

Sep. 9, 1998

FDA OKs Shield Diagnostics' Test For Blood Clotting Factor

Sep. 9, 1998

IDM Financing Nets US$15M For Cell-Based Cancer Therapies

Sep. 9, 1998

Non-Pathogenic Bacteria May Deliver DNA Vaccines, Therapeutic Genes

Sep. 9, 1998

Xenova Raises £9.6M To Push Anticancer, MDR Drug Trials

Sep. 9, 1998

MorphoSys Postpones Listing, Cites Global Market Turmoil

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...